Instil Bio (TIL) Preferred Stock Liabilities (2020)

Instil Bio has reported Preferred Stock Liabilities for 1 years, with the latest figure at $332.0 million in Q4 2020.

• On a quarterly basis, Preferred Stock Liabilities changed N/A year-over-year to $332.0 million in Q4 2020; TTM through Dec 2020 was $332.0 million, a N/A change from a year earlier, with the FY2020 full-year figure at $332.0 million, changed N/A from the prior year.
• Preferred Stock Liabilities was $332.0 million for Q4 2020 at Instil Bio, up from $199.2 million in the prior quarter.
• The five-year high for Preferred Stock Liabilities was $332.0 million in Q4 2020, with the low at $14.9 million in Q1 2020.